Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
15.76
+0.62 (4.10%)
Oct 8, 2025, 2:21 PM EDT - Market open

Edgewise Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
1,6602,528694565753-
Upgrade
Market Cap Growth
-37.39%264.15%22.85%-24.97%--
Upgrade
Enterprise Value
1,0742,040410203463-
Upgrade
Last Close Price
15.1426.7010.948.9415.28-
Upgrade
PB Ratio
2.715.512.181.632.75-
Upgrade
P/TBV Ratio
2.825.512.181.632.75-
Upgrade
Debt / Equity Ratio
0.010.010.020.01--
Upgrade
Quick Ratio
28.4319.7018.9921.2226.6929.73
Upgrade
Current Ratio
28.8719.9319.5021.5326.9729.86
Upgrade
Return on Equity (ROE)
-27.41%-34.40%-30.10%-21.78%-21.34%-22.80%
Upgrade
Return on Assets (ROA)
-19.05%-24.01%-20.21%-13.73%-12.97%-13.80%
Upgrade
Return on Capital (ROIC)
-19.68%-25.19%-21.17%-14.32%-13.46%-14.31%
Upgrade
Earnings Yield
-9.06%-5.29%-14.43%-11.97%-5.68%-
Upgrade
FCF Yield
-7.55%-4.36%-14.07%-10.29%-4.54%-
Upgrade
Buyback Yield / Dilution
-25.66%-45.02%-18.90%-42.82%-4977.96%-95.63%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q